Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › steroids

steroids

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of steroids

11 trials tracked of steroids: 8 in phase 3 or 4 and 1 with published results. The most-cited published study has 12 citations.

11Trials tracked
8Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 4 Phase 3 4 Phase 2 3
  1. Phase 3 Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children Completed · 12 cited
  2. Phase 4 Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation Completed
  3. Phase 4 ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients Completed
  4. Phase 4 Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients Completed
  5. Phase 4 Steroid Free Immunosuppression in Liver Transplantation Completed
  6. Phase 3 Everolimus in de Novo Kidney Transplant Recipients Completed
Show 5 more trials
  1. Phase 3 RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency Completed
  2. Phase 3 Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance. Completed
  3. Phase 2 Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease Completed
  4. Phase 2 A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients Completed
  5. Phase 2 Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Adjunctive steroids reduce mortality in adult TB meningitis patients but not in children
Pediatrics Meta-analysis
Adjunctive steroids reduce mortality in adult TB meningitis patients but not in children Steroids may lower death rates for adults with TB meningitis
This meta-analysis of 2028 patients found that adjunctive steroid therapy significantly reduced mortality in adults with TB meningitis (RR =…
Adding steroids to treatment can reduce deaths in adults with TB meningitis, but the results are not as clear for children.
Jul 21, 2026
WBRT yields median survival of 3.6 months in Nigerian brain metastases patients
Oncology Meta-analysis
WBRT yields median survival of 3.6 months in Nigerian brain metastases patients Brain radiation extends life by 3.6 months in Nigerian patients
This systematic review of 142 patients with brain metastases in Nigeria found that whole brain radiotherapy (WBRT) was associated with a med…
Whole brain radiotherapy gave Nigerian breast cancer patients with brain metastases a median survival of 3.6 months. A new review reveals th…
Frontiers Jun 17, 2026
Steroid avoidance may reduce death and diabetes after kidney transplant but raises rejection risk
Cardiology Sys. Review
Steroid avoidance may reduce death and diabetes after kidney transplant but raises rejection risk Steroid avoidance after kidney transplant may reduce death and diabetes
This systematic review of 53 studies (8317 participants) found that steroid avoidance may reduce all-cause death at 1-5 years and post-trans…
Skipping steroids after a kidney transplant might lower the risk of death and diabetes, but could raise the chance of rejection.
Cochrane Jun 2, 2026
Guideline secondary analysis shows non-significant trend for higher enteral nutrition use in pediatric Crohn's disease registry groups
Pediatrics Guideline
Guideline secondary analysis shows non-significant trend for higher enteral nutrition use in pediatric Crohn's disease registry groups Registry tool shows mixed results for pediatric Crohn's nutrition
This guideline secondary analysis of a cluster-randomized trial examines enteral nutrition patterns in 110 children with Crohn's disease. Th…
A new registry tool did not significantly boost enteral nutrition use in children with Crohn's, but it may lower steroid use in the first 90…
Frontiers May 26, 2026
Switching therapy after rituximab resistance in AQP4-IgG+ NMOSD shows variable relapse outcomes
Oncology Cohort
Switching therapy after rituximab resistance in AQP4-IgG+ NMOSD shows variable relapse outcomes New Hope for Tough-to-Treat Nerve Disorder
This single-center, retrospective case series of 10 adults with AQP4-IgG+ NMOSD who were resistant to rituximab evaluated switching therapy.
Patients with a rare nerve disease who stopped responding to standard treatment found relief after switching to new therapies that prevented…
Frontiers Apr 19, 2026